SHIVA GUPTA to Blood-Brain Barrier
This is a "connection" page, showing publications SHIVA GUPTA has written about Blood-Brain Barrier.
Connection Strength
0.332
-
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma. Mol Cancer Ther. 2017 Dec; 16(12):2735-2746.
Score: 0.132
-
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma. Clin Cancer Res. 2015 Apr 15; 21(8):1916-24.
Score: 0.110
-
Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors. J Pharmacol Exp Ther. 2022 10; 383(1):91-102.
Score: 0.046
-
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. Neuro Oncol. 2021 12 01; 23(12):2042-2053.
Score: 0.044